IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Other sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 33.7GRADE D
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
-13.2%
Sector: 7.7%
Dividend Analysis audit
No Dividend
This company does not currently pay a dividend.
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, Enhabit, Inc. (EHAB) receives a "Hold" rating with a composite score of 48.6/100, ranked #614 out of 4446 stocks. Key factor scores: Quality 34/100, Value 46/100, Momentum 68/100. This is quantitative analysis only — not investment advice.
Enhabit, Inc. (EHAB) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does Enhabit, Inc. Do?
N/A Enhabit, Inc. (EHAB) is classified as a small-cap stock in the Other sector, specifically within the Healthcare industry. The company is led by CEO N/A and employs approximately 10,900 people. With a market capitalization of $709M, EHAB is one of the notable companies in the Other sector.
Enhabit, Inc. (EHAB) Stock Rating — Hold (April 2026)
As of April 2026, Enhabit, Inc. receives a Hold rating with a composite score of 48.6/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.EHAB ranks #614 out of 4,446 stocks in our coverage universe. Within the Other sector, Enhabit, Inc. ranks #4 of 37 stocks, placing it in the top quartile of its Other peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
EHAB Stock Price and 52-Week Range
Enhabit, Inc. (EHAB) currently trades at $13.98. The stock lost $0.01 (0.0%) in the most recent trading session. The 52-week high for EHAB is $13.65, which means the stock is currently trading 2.4% from its annual peak. The 52-week low is $6.47, putting the stock 116.2% above its annual trough. Recent trading volume was 113K shares, suggesting relatively thin trading activity.
Is EHAB Overvalued or Undervalued? — Valuation Analysis
Enhabit, Inc. (EHAB) carries a value factor score of 46/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 61.82x, compared to the Other sector average of 17.96x — a premium of 244%. The price-to-book ratio stands at 1.27x, versus the sector average of 1.35x. The price-to-sales ratio is 0.68x, compared to 1.01x for the average Other stock. On an enterprise value basis, EHAB trades at 11.02x EV/EBITDA, versus 9.83x for the sector.
Overall, EHAB's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
Enhabit, Inc. Profitability — ROE, Margins, and Quality Score
Enhabit, Inc. (EHAB) earns a quality factor score of 34/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -13.2%, compared to the Other sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -6.3% versus the sector average of 2.1%.
On a margin basis, Enhabit, Inc. reports gross margins of 48.5%, compared to 47.4% for the sector. The operating margin is -5.0% (sector: 2.2%). Net profit margin stands at -7.4%, versus 6.3% for the average Other stock. Revenue growth is running at 1.1% on a trailing basis, compared to 7.8% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
EHAB Debt, Balance Sheet, and Financial Health
Enhabit, Inc. has a debt-to-equity ratio of 108.0%, compared to the Other sector average of 92.5%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 1.63x, suggesting adequate working capital coverage. Cash and equivalents stand at $57M.
EHAB has a beta of 0.81, meaning it is roughly in line with the broader market in terms of price volatility. The stability factor score for Enhabit, Inc. is 65/100, reflecting average volatility within the normal range for its sector.
Enhabit, Inc. Revenue and Earnings History — Quarterly Trend
In TTM 2026, Enhabit, Inc. reported revenue of $1.04B and earnings per share (EPS) of $-0.09. Net income for the quarter was $-74M. Operating income came in at $-49M.
In FY 2025, Enhabit, Inc. reported revenue of $1.06B and earnings per share (EPS) of $-0.09. Net income for the quarter was $-3M. Revenue grew 2.4% year-over-year compared to FY 2024. Operating income came in at $16M.
In Q3 2025, Enhabit, Inc. reported revenue of $264M and earnings per share (EPS) of $0.22. Net income for the quarter was $12M. Revenue grew 3.9% year-over-year compared to Q3 2024. Operating income came in at $17M.
In Q2 2025, Enhabit, Inc. reported revenue of $266M and earnings per share (EPS) of $0.10. Net income for the quarter was $6M. Revenue grew 2.1% year-over-year compared to Q2 2024. Operating income came in at $17M.
Over the past 8 quarters, Enhabit, Inc. has demonstrated a growth trajectory, with revenue expanding from $261M to $1.04B. Investors analyzing EHAB stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
EHAB Dividend Yield and Income Analysis
Enhabit, Inc. (EHAB) does not currently pay a dividend. This is common among smaller companies in the Healthcare industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Other dividend stocks may want to explore other Other stocks or use the stock screener to filter by dividend yield.
EHAB Momentum and Technical Analysis Profile
Enhabit, Inc. (EHAB) has a momentum factor score of 68/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 33/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 48/100 reflects moderate short selling activity.
EHAB vs Competitors — Other Sector Ranking and Peer Comparison
Comparing EHAB against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full EHAB vs S&P 500 (SPY) comparison to assess how Enhabit, Inc. stacks up against the broader market across all factor dimensions.
EHAB Next Earnings Date
No upcoming earnings date has been announced for Enhabit, Inc. (EHAB) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy EHAB? — Investment Thesis Summary
Enhabit, Inc. presents a balanced picture with arguments on both sides. The quality score of 34/100 flags below-average profitability. Price momentum is positive at 68/100, suggesting the trend favors buyers. Low volatility (stability score 65/100) reduces downside risk.
In summary, Enhabit, Inc. (EHAB) earns a Hold rating with a composite score of 48.6/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on EHAB stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
Enhabit, Inc. (EHAB) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
Enhabit, Inc. (EHAB) receives a Hold rating, driven by a mixed financial performance and a valuation that appears stretched relative to its profitability. While the company has demonstrated some positive momentum in recent quarters, its historical struggles with profitability and negative margins raise concerns about its long-term sustainability and ability to generate consistent returns for investors. The current valuation, particularly the high P/E ratio compared to the sector, suggests that the market may be pricing in future growth that is not yet supported by the company's fundamentals.
The key takeaway is that Enhabit's turnaround is still in progress, and significant improvements in operational efficiency and profitability are needed to justify a more optimistic outlook. Investors should closely monitor the company's ability to sustain positive net income and improve its operating margins in the coming quarters before considering a more bullish stance.
Business Strategy & Overview
Enhabit, Inc. operates within the healthcare sector, likely providing home health and hospice services. Without specific details on their business model, we can infer that revenue is generated through providing care to patients in their homes or in hospice facilities, reimbursed by a combination of government programs (Medicare/Medicaid) and private insurance. The company's strategic positioning likely involves building a network of care providers and facilities, managing costs effectively, and maintaining compliance with healthcare regulations.
Given the fragmented nature of the home health and hospice industry, Enhabit's strategy likely focuses on achieving scale and operational efficiencies. This could involve acquisitions of smaller providers, investments in technology to improve care coordination and reduce administrative costs, and efforts to attract and retain qualified healthcare professionals. The company's ability to differentiate itself from competitors may depend on factors such as the quality of care provided, the breadth of services offered, and its reputation within the communities it serves.
The healthcare industry is subject to significant regulatory oversight, particularly regarding reimbursement rates and quality standards. Enhabit's business strategy must therefore incorporate a strong focus on compliance and advocacy to ensure favorable reimbursement policies and maintain its licenses and certifications. Furthermore, the company must adapt to evolving trends in healthcare delivery, such as the increasing emphasis on value-based care and the use of telehealth technologies.
Based on the provided financial data, Enhabit appears to be in a turnaround phase. The company's recent quarterly performance shows improvements in net income and operating margins compared to the previous year, suggesting that management's efforts to improve profitability are beginning to bear fruit. However, the company's historical struggles with profitability and negative margins highlight the challenges it faces in a competitive and highly regulated industry.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
1.1%
Sector: 7.8%
-85% VS SCTR
Economic Moat Analysis
Assessing Enhabit's economic moat is challenging without detailed information about its specific operations and competitive landscape. However, based on the general characteristics of the home health and hospice industry, it is likely that Enhabit possesses a narrow or no moat. The industry is relatively fragmented, with numerous providers competing for patients and referral sources.
One potential source of competitive advantage could be intangible assets, such as a strong brand reputation or proprietary technology. However, without evidence of significant brand recognition or unique technological capabilities, it is unlikely that Enhabit possesses a durable advantage in this area. Switching costs for patients in home health and hospice care are generally low, as patients can easily switch providers if they are dissatisfied with the quality of care or the level of service.
Network effects are unlikely to be a significant source of competitive advantage for Enhabit. While the company may benefit from referrals from physicians and hospitals, these relationships are typically not exclusive and can be easily replicated by competitors. Cost advantages could potentially arise from economies of scale or superior operational efficiency. However, the company's historical struggles with profitability suggest that it has not yet achieved a significant cost advantage over its competitors.
Efficient scale, where a market is effectively served by a limited number of providers, may exist in certain geographic areas. If Enhabit has a dominant market share in a particular region, it may be able to exert some pricing power and achieve higher margins. However, this advantage is likely to be limited by the presence of other providers and the potential for new entrants.
Given the competitive nature of the industry and the lack of clear sources of durable competitive advantage, it is reasonable to conclude that Enhabit's economic moat is either narrow or nonexistent. The company's ability to generate sustainable profits and returns for investors will depend on its ability to execute its turnaround strategy and differentiate itself from competitors through superior quality of care, operational efficiency, or other factors.
Financial Health & Profitability
Enhabit's financial health presents a mixed picture. The company's revenue has remained relatively stable over the past few years, with a slight increase from $1.03 billion in FY2024 to $1.06 billion in FY2025, representing a growth of approximately 1.2%. However, this growth rate is significantly lower than the sector average of 7.9%, indicating that Enhabit is underperforming its peers in terms of revenue generation.
Profitability has been a significant challenge for Enhabit. The company reported net losses in FY2023 and FY2024, with net income improving to a loss of $2.6 million in FY2025. While this represents a significant improvement, the company is still not generating consistent profits. The company's operating margin has also been volatile, with negative margins in FY2023 and FY2024, followed by a positive margin of 1.5% in FY2025. This suggests that the company's cost structure is not well-aligned with its revenue generation.
Compared to the sector, Enhabit's profitability metrics are significantly weaker. The company's net margin of -7.4% is significantly lower than the sector average of 6.3%, and its ROE of -13.2% is also significantly lower than the sector average of 7.7%. This indicates that Enhabit is not generating sufficient returns on its equity investments.
The company's balance sheet appears to be relatively healthy, with a current ratio of 1.63, indicating that it has sufficient liquid assets to cover its short-term liabilities. However, the company's debt-to-equity ratio of 108.00 is higher than the sector average of 87.00, suggesting that it is more leveraged than its peers. The absence of free cash flow data makes it difficult to assess the company's ability to generate cash from its operations.
The quarterly financial history reveals a positive trend in recent quarters, with net income and operating margins improving sequentially. This suggests that the company's turnaround efforts are gaining traction. However, it is important to note that the company's performance has been volatile in the past, and there is no guarantee that this positive trend will continue.
Valuation Assessment
Enhabit's valuation presents a complex picture. The company's P/E ratio of 61.8x is significantly higher than the sector average of 19.5x, suggesting that the stock is overvalued relative to its earnings. However, it's important to note that the company's recent earnings have been volatile, and the P/E ratio may not be a reliable indicator of value in this case.
The company's EV/EBITDA ratio of 10.7x is slightly higher than the sector average of 9.7x, suggesting that the stock is fairly valued relative to its enterprise value and earnings before interest, taxes, depreciation, and amortization. However, EBITDA can be a misleading metric for companies with significant capital expenditures or working capital requirements.
Without free cash flow data, it is difficult to assess the company's valuation based on its ability to generate cash. However, the company's historical struggles with profitability and negative margins suggest that its free cash flow generation may be limited.
Given the company's high P/E ratio, its slightly elevated EV/EBITDA ratio, and its historical struggles with profitability, it is reasonable to conclude that the stock is currently fairly to slightly overvalued. The market may be pricing in future growth that is not yet supported by the company's fundamentals. Investors should closely monitor the company's ability to sustain positive net income and improve its operating margins before considering a more bullish stance.
The Momentum score of 63 suggests that the stock has been performing well recently, which could be contributing to the elevated valuation. However, it is important to remember that momentum can be fleeting, and past performance is not necessarily indicative of future results.
Risk & Uncertainty
Enhabit faces several risks and uncertainties that could impact its financial performance and valuation. One of the most significant risks is regulatory risk. The healthcare industry is subject to significant regulatory oversight, particularly regarding reimbursement rates and quality standards. Changes in government policies or regulations could negatively impact the company's revenue and profitability.
Competition is another significant risk. The home health and hospice industry is relatively fragmented, with numerous providers competing for patients and referral sources. Enhabit faces competition from both large national chains and smaller regional providers. The company's ability to maintain its market share and profitability will depend on its ability to differentiate itself from competitors and provide high-quality care at competitive prices.
Concentration risk is also a concern. Enhabit may be reliant on a small number of key referral sources, such as hospitals or physicians. The loss of one or more of these referral sources could negatively impact the company's revenue and profitability. The company's reliance on government reimbursement programs, such as Medicare and Medicaid, also exposes it to concentration risk.
Leverage is another potential risk. The company's debt-to-equity ratio of 108.00 is higher than the sector average, suggesting that it is more leveraged than its peers. High levels of debt can increase the company's financial risk and limit its ability to invest in growth opportunities.
Bulls Say / Bears Say
The Bull Case
BULL VIEWEnhabit's recent quarterly improvements in net income and operating margins signal a successful turnaround, making it an attractive investment at its current price.
BULL VIEWThe aging population and increasing demand for home healthcare services provide a strong tailwind for Enhabit, driving future revenue growth and profitability.
The Bear Case
BEAR VIEWEnhabit's high P/E ratio and negative ROE indicate that the stock is overvalued and the company is not generating sufficient returns for investors.
BEAR VIEWThe company's high debt-to-equity ratio and reliance on government reimbursement programs expose it to significant financial and regulatory risks.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score EHAB and 4,400+ other equities.
Enhabit, Inc. exhibits a 54% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
-6.3%
Sector: 2.1%
Gross Margin
Pricing power and cost efficiency
48.5%
Sector: 47.4%
Operating Margin
Core business profitability
-5.0%
Sector: 2.2%
Net Margin
Bottom-line profitability
-7.4%
Sector: 6.3%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
